Pesquisa | BVS Doenças Infecciosas e Parasitárias

1.

Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice.

Du, Wan-Ying; Masuda, Hiroki; Nagaoka, Koji; Yasuda, Tomohiko; Kuge, Komei; Seto, Yasuyuki; Kakimi, Kazuhiro; Nomura, Sachiyo.

Gastric Cancer ; 2024 May 28.

Artigo em Inglês | MEDLINE | ID: mdl-38805119

2.

Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.

Izawa, Mizuki; Tanaka, Nobuyuki; Murakami, Tetsushi; Anno, Tadatsugu; Teranishi, Yu; Takamatsu, Kimiharu; Mikami, Shuji; Kakimi, Kazuhiro; Imamura, Takeshi; Matsumoto, Kazuhiro; Oya, Mototsugu.

Lab Invest ; 103(4): 100040, 2023 04.

Artigo em Inglês | MEDLINE | ID: mdl-36870289

3.

Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors.

Sun, Changbo; Nagaoka, Koji; Kobayashi, Yukari; Maejima, Kazuhiro; Nakagawa, Hidewaki; Nakajima, Jun; Kakimi, Kazuhiro.

Int J Cancer ; 152(7): 1463-1475, 2023 04 01.

Artigo em Inglês | MEDLINE | ID: mdl-36451303

4.

Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.

Kurebayashi, Yutaka; Tsujikawa, Hanako; Sugimoto, Katsutoshi; Yunaiyama, Daisuke; Araki, Yoichi; Saito, Kazuhiro; Takahashi, Hiroshi; Kakegawa, Tatsuya; Wada, Takuya; Tomita, Yusuke; Abe, Masakazu; Yoshimasu, Yu; Takeuchi, Hirohito; Hirata, Taiki; Sakamaki, Kentaro; Kakimi, Kazuhiro; Nagao, Toshitaka; Itoi, Takao; Sakamoto, Michiie.

Hepatol Res ; 53(10): 1008-1020, 2023 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-37300323

5.

Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer.

Sato, Yasuyoshi; Yamashita, Hiroharu; Kobayashi, Yukari; Nagaoka, Koji; Hisayoshi, Tetsuro; Kawahara, Takuya; Kuroda, Akihiro; Saito, Noriyuki; Iwata, Ryohei; Okumura, Yasuhiro; Yagi, Koichi; Aiko, Susumu; Nomura, Sachiyo; Kakimi, Kazuhiro; Seto, Yasuyuki.

Int J Mol Sci ; 24(23)2023 Nov 22.

Artigo em Inglês | MEDLINE | ID: mdl-38068925

6.

Association between effector-type regulatory T cells and immune checkpoint expression on CD8⁺ T cells in malignant ascites from epithelial ovarian cancer.

Sato, Sho; Matsushita, Hirokazu; Shintani, Daisuke; Kobayashi, Yukari; Fujieda, Nao; Yabuno, Akira; Nishikawa, Tadaaki; Fujiwara, Keiichi; Kakimi, Kazuhiro; Hasegawa, Kosei.

BMC Cancer ; 22(1): 437, 2022 Apr 21.

Artigo em Inglês | MEDLINE | ID: mdl-35449092

7.

[Understanding Tumor Immunity by Immune Genome Profiling of the Cancer Tissue].

Kakimi, Kazuhiro.

Gan To Kagaku Ryoho ; 49(3): 255-258, 2022 Mar.

Artigo em Japonês | MEDLINE | ID: mdl-35299176

8.

Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.

Hakozaki, Kyohei; Tanaka, Nobuyuki; Takamatsu, Kimiharu; Takahashi, Ryohei; Yasumizu, Yota; Mikami, Shuji; Shinojima, Toshiaki; Kakimi, Kazuhiro; Kamatani, Takashi; Miya, Fuyuki; Tsunoda, Tatsuhiko; Aimono, Eriko; Nishihara, Hiroshi; Mizuno, Ryuichi; Oya, Mototsugu.

Br J Cancer ; 125(11): 1533-1543, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34611307

9.

Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.

Murakami, Tetsushi; Tanaka, Nobuyuki; Takamatsu, Kimiharu; Hakozaki, Kyohei; Fukumoto, Keishiro; Masuda, Tsukasa; Mikami, Shuji; Shinojima, Toshiaki; Kakimi, Kazuhiro; Tsunoda, Tatsuhiko; Sawada, Kazuaki; Imamura, Takeshi; Mizuno, Ryuichi; Oya, Mototsugu.

Cancer Immunol Immunother ; 70(10): 3001-3013, 2021 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-34259900

10.

Adoptive Î³Î´T-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancer.

Sato, Yasuyoshi; Mori, Kazuhiko; Hirano, Kosuke; Yagi, Koichi; Kobayashi, Yukari; Nagaoka, Koji; Hosoi, Akihiro; Matsushita, Hirokazu; Kakimi, Kazuhiro; Seto, Yasuyuki.

Cytotherapy ; 23(5): 423-432, 2021 05.

Artigo em Inglês | MEDLINE | ID: mdl-33781711

11.

A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions.

Kobayashi, Yukari; Kushihara, Yoshihiro; Saito, Noriyuki; Yamaguchi, Shigeo; Kakimi, Kazuhiro.

Cancer Sci ; 111(11): 4031-4040, 2020 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-32810311

12.

Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method.

Ma, Liqiu; Sakamoto, Yoshimitsu; Kanai, Akinori; Otsuka, Hiromi; Takahashi, Akihisa; Kakimi, Kazuhiro; Imai, Takashi; Shimokawa, Takashi.

Int J Mol Sci ; 21(8)2020 Apr 18.

Artigo em Inglês | MEDLINE | ID: mdl-32325684

13.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

Isogawa, Masanori; Chung, Josan; Murata, Yasuhiro; Kakimi, Kazuhiro; Chisari, Francis V.

PLoS Pathog ; 13(5): e1006416, 2017 May.

Artigo em Inglês | MEDLINE | ID: mdl-28562694

14.

Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.

Sugimoto, Katsutoshi; Kakimi, Kazuhiro; Takeuchi, Hirohito; Fujieda, Nao; Saito, Kazuhiro; Sato, Eiichi; Sakamaki, Kentaro; Moriyasu, Fuminori; Itoi, Takao.

J Vasc Interv Radiol ; 30(6): 845-853.e6, 2019 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-31126596

15.

NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer.

Hoshikawa, Mayumi; Aoki, Taku; Matsushita, Hirokazu; Karasaki, Takahiro; Hosoi, Akihiro; Odaira, Kosuke; Fujieda, Nao; Kobayashi, Yukari; Kambara, Kaori; Ohara, Osamu; Arita, Junichi; Hasegawa, Kiyoshi; Kakimi, Kazuhiro; Kokudo, Norihiro.

Biochem Biophys Res Commun ; 495(2): 2058-2065, 2018 01 08.

Artigo em Inglês | MEDLINE | ID: mdl-29253566

16.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

Isogawa, Masanori; Chung, Josan; Murata, Yasuhiro; Kakimi, Kazuhiro; Chisari, Francis V.

PLoS Pathog ; 12(12): e1006086, 2016 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-27926947

17.

[Re-Analysis of Cancer Vaccine Patients with Immune-Related Clinical Response Criteria(irRC)].

Nishida, Kentaro; Saito, Takuro; Urakawa, Shinya; Mori, Masaki; Kakimi, Kazuhiro; Doki, Yuichiro; Wada, Hisashi.

Gan To Kagaku Ryoho ; 45(10): 1466-1468, 2018 Oct.

Artigo em Japonês | MEDLINE | ID: mdl-30382047

18.

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.

Karasaki, Takahiro; Nagayama, Kazuhiro; Kuwano, Hideki; Nitadori, Jun-Ichi; Sato, Masaaki; Anraku, Masaki; Hosoi, Akihiro; Matsushita, Hirokazu; Takazawa, Masaki; Ohara, Osamu; Nakajima, Jun; Kakimi, Kazuhiro.

Cancer Sci ; 108(2): 170-177, 2017 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-27960040

19.

Adjuvant combination therapy with gemcitabine and autologous Î³Î´ T-cell transfer in patients with curatively resected pancreatic cancer.

Aoki, Taku; Matsushita, Hirokazu; Hoshikawa, Mayumi; Hasegawa, Kiyoshi; Kokudo, Norihiro; Kakimi, Kazuhiro.

Cytotherapy ; 19(4): 473-485, 2017 04.

Artigo em Inglês | MEDLINE | ID: mdl-28188072

20.

Î³Î´ T cell-based cancer immunotherapy.

Matsushita, Hirokazu; Kakimi, Kazuhiro.

Nihon Rinsho ; 75(2): 301-305, 2017 02.

Artigo em Japonês | MEDLINE | ID: mdl-30562868

BVS Doenças Infecciosas e Parasitárias

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Janus kinase inhibitor overcomes resistance to immune checkpoint inhibitor treatment in peritoneal dissemination of gastric cancer in C57BL/6 J mice.

Single-Cell Phenotyping of CD73 Expression Reveals the Diversity of the Tumor Immune Microenvironment and Reflects the Prognosis of Bladder Cancer.

Immunotherapies targeting neoantigens are effective in PD-1 blockade-resistant tumors.

Tumor steatosis and glutamine synthetase expression in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab therapy.

Alterations in Intratumoral Immune Response before and during Early-On Nivolumab Treatment for Unresectable Advanced or Recurrent Gastric Cancer.

Association between effector-type regulatory T cells and immune checkpoint expression on CD8⁺ T cells in malignant ascites from epithelial ovarian cancer.

[Understanding Tumor Immunity by Immune Genome Profiling of the Cancer Tissue].

Landscape of prognostic signatures and immunogenomics of the AXL/GAS6 axis in renal cell carcinoma.

Multiplexed single-cell pathology reveals the association of CD8 T-cell heterogeneity with prognostic outcomes in renal cell carcinoma.

Adoptive Î³Î´T-cell transfer alone or combined with chemotherapy for the treatment of advanced esophageal cancer.

A novel scoring method based on RNA-Seq immunograms describing individual cancer-immunity interactions.

Characterization of a Novel Murine Colon Carcinoma Subline with High-Metastatic Activity Established by In Vivo Selection Method.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

Irreversible Electroporation versus Radiofrequency Ablation: Comparison of Systemic Immune Responses in Patients with Hepatocellular Carcinoma.

NK cell and IFN signatures are positive prognostic biomarkers for resectable pancreatic cancer.

Correction: CD40 Activation Rescues Antiviral CD8+ T Cells from PD-1-Mediated Exhaustion.

[Re-Analysis of Cancer Vaccine Patients with Immune-Related Clinical Response Criteria(irRC)].

Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.

Adjuvant combination therapy with gemcitabine and autologous Î³Î´ T-cell transfer in patients with curatively resected pancreatic cancer.

Î³Î´ T cell-based cancer immunotherapy.